Callan Family Office LLC grew its position in Novanta Inc. (NASDAQ:NOVT – Free Report) by 65.8% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,117 shares of the technology company’s stock after acquiring an additional 2,031 shares during the period. Callan Family Office LLC’s holdings in Novanta were worth $660,000 at the end of the most recent quarter.
Other large investors have also modified their holdings of the company. GAMMA Investing LLC raised its position in shares of Novanta by 146.0% during the 1st quarter. GAMMA Investing LLC now owns 401 shares of the technology company’s stock worth $51,000 after purchasing an additional 238 shares during the last quarter. Conestoga Capital Advisors LLC grew its stake in Novanta by 1.3% during the 1st quarter. Conestoga Capital Advisors LLC now owns 1,365,252 shares of the technology company’s stock valued at $174,575,000 after acquiring an additional 17,220 shares in the last quarter. State of Alaska Department of Revenue grew its stake in Novanta by 2.6% during the 1st quarter. State of Alaska Department of Revenue now owns 4,201 shares of the technology company’s stock valued at $537,000 after acquiring an additional 105 shares in the last quarter. WoodTrust Financial Corp grew its stake in Novanta by 11.5% during the 1st quarter. WoodTrust Financial Corp now owns 2,433 shares of the technology company’s stock valued at $311,000 after acquiring an additional 250 shares in the last quarter. Finally, Bessemer Group Inc. grew its stake in Novanta by 4.0% during the 1st quarter. Bessemer Group Inc. now owns 151,430 shares of the technology company’s stock valued at $19,362,000 after acquiring an additional 5,818 shares in the last quarter. Institutional investors and hedge funds own 98.35% of the company’s stock.
Novanta Stock Up 3.2%
NOVT stock opened at $103.12 on Tuesday. The company has a current ratio of 2.54, a quick ratio of 1.62 and a debt-to-equity ratio of 0.57. The company has a market cap of $3.71 billion, a P/E ratio of 60.66 and a beta of 1.49. The company’s 50-day moving average price is $112.31 and its 200 day moving average price is $119.20. Novanta Inc. has a 52 week low of $98.76 and a 52 week high of $184.11.
Novanta announced that its board has initiated a stock repurchase program on Thursday, September 18th that allows the company to buyback $200.00 million in shares. This buyback authorization allows the technology company to purchase up to 4.9% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its shares are undervalued.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on NOVT shares. Wall Street Zen cut shares of Novanta from a “buy” rating to a “hold” rating in a research note on Monday, August 11th. Zacks Research upgraded shares of Novanta from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Robert W. Baird dropped their target price on shares of Novanta from $139.00 to $133.00 and set a “neutral” rating for the company in a report on Monday, August 11th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Novanta in a report on Wednesday, October 8th. Three equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $133.00.
Read Our Latest Stock Report on Novanta
Novanta Profile
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Featured Stories
- Five stocks we like better than Novanta
- The Most Important Warren Buffett Stock for Investors: His Own
- FICO’s Big Dip Could Be the Best Buying Chance of the Year
- How to Calculate Inflation Rate
- D-Wave: Reevaluating the Short Seller’s Case After the Downgrade
- What Are Treasury Bonds?
- Datavault: A Speculative AI Play, But Beware of Volatility
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.